pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-637 |
Genomic Coordinates | chr19: 3961414 - 3961512 |
Synonyms | MIRN637, hsa-mir-637, MIR637 |
Description | Homo sapiens miR-637 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-637 | |||||||||||||||||||||||||||||||||||||||
Sequence | 61| ACUGGGGGCUUUCGGGCUCUGCGU |84 | |||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | SAGE | |||||||||||||||||||||||||||||||||||||||
Expression Profile | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CLSTN1 | ||||||||||||||||||||
Synonyms | ALC-ALPHA, CDHR12, CST-1, CSTN1, PIK3CD, XB31alpha, alcalpha1, alcalpha2 | ||||||||||||||||||||
Description | calsyntenin 1 | ||||||||||||||||||||
Transcript | NM_001009566 | ||||||||||||||||||||
Other Transcripts | NM_014944 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CLSTN1 | |||||||||||||||||||||
3'UTR of CLSTN1 (miRNA target sites are highlighted) |
>CLSTN1|NM_001009566|3'UTR 1 CCCGTGCCCCCGGCCACCTCGGTTTCTGCTTTCGAAGACTCTGCTGCCATCCGTTCTCCCAGTCCCAAGGGTCCACGATG 81 TACAAAGTCATTTCGGCCAGTAGGTGTGCAGACCCCTCCCCGCCACGATCGTCGCTGTGCTTGGTGTGTAGGACCCTAGG 161 CTCCCCGCCCACCCTCTGCCTGGTCGCGCTCTTCAGTCCCACGAGGAGCTGACACGTCCTCTCTGGCCGCCATCCGGCTC 241 GCACAGGGGCCTCCCAGCGCCTCAGGCCCCGCGTTTGTGTCTGGAGTCTCCCCCCGGGGAGAGGACACTGGCCCCTCGCA 321 CTCCAGAAAAGCCATGCCAGCTGGGCTCGTTGACAAAGGGTAAAACATGCTCACTCCCACCCGGTAATCATTTTTTTCTT 401 TTTTTAAAAAAAGTTTTTATTTTTTCCAAACTAGTGCATGTATAAATAATGGCAGGATGGGGGGTACTGTGTAGATGATT 481 AACTGACTTTTTAATATTTTGTAAATAAATCGGATTCCTTGTGTCCTTTGTGCTAGTGTAACCCGGGACTGGAATGTAAA 561 GTGAAGTTCGGAGCTCTGAGCACGGGCTCTTCCCGCCGGGTCCTCCCTCCCCAGACCCCAGAGGGAGAGGCCCACCCCGC 641 CCAGCCCCGCCCCAGCCCCTGCTCAGGTCTGAGTATGGCTGGGAGTCGGGGGCCACAGGCCTCTAGCTGTGCTGCTCAAG 721 AGACTGGATCAGGGTAGCTACAAGTGGCCGGGCCTTGCCTTTGGGATTCTACCTGTTCCTAATTTGGTGTGGGGTGCGGG 801 GTCCCTGGCCCCTTTTCCACACTCCTCCTCCGACAGCAGCTCCCTGGGCAGTGGCCTGGTCTCACCGTGTGCAGCCTTGT 881 GGTTTATGCTTAAATGTACATTTTCCTGCTGGTAAAAGGAGAAACTGAGAGGTGTCCTGCAGACCGGCTGACCACTCCTT 961 TTGGAGACGGCAGGAGGCCTGAGCGATCCGTACTCAGAACGTCCAGGAGAGACGCATGGCCCGAAGTCAAAGTGCTGGAA 1041 TTTTCCAAAACAGCCTGTTCTCTCCTCTCTCCTCCCCAGAGCACCCCCTGCCATCAGGGGGGTTGAAATCCCTCTCCCCC 1121 AGGAGCCCTGCTGCTTTGCTTGGTGGTAGGGCAGGAGAGCAAACAAACAGTCATGGTCTAAAACCCACATAGCACTTTGC 1201 TCTTAGTTACATGTAAAATTTTAGATTTCTAAAACAGGTGGGCAATCATTTTGAATACTGTTCTGTGACCCTGACTGCTA 1281 GTTCTGAGGACACTGGTGGCTGTGCTATGTGTGGCCATCCTCCATGTCCCGTCCCTGTAGCTGCTCTGTTTAGACAGCGG 1361 ACAGACGCTCACGCCCAGGGGATGTCCTCACGCTGTCGCCGCGCGGTTTCCCTTCGCAGATGTGTATACTCATGATAGGT 1441 CAGAAAGTGTATCCGCTACAATAAAGTTCTGGTTCTAACTAACTCCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
PAR-CLIP data was present in ERX177602. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_4
PAR-CLIP data was present in ERX177609. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_11
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177614. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_4
PAR-CLIP data was present in ERX177617. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_7
PAR-CLIP data was present in ERX177621. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_11
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177628. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_6
PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11
PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5
PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7
PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8
PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_014944 | 3UTR | CUCCCCCAGGAGCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_014944 | 3UTR | CUCCCCCAGGAGCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000377298.4 | 3UTR | UCCCGCCGGGUCCUCCCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000377298.4 | 3UTR | UCCCGCCGGGUCCUCCCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000377298.4 | 3UTR | CGGGCUCUUCCCGCCGGGUCCUCCCUCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
69 hsa-miR-637 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT006147 | SP7 | Sp7 transcription factor | 3 | 1 | ||||||||
MIRT054906 | COL4A1 | collagen type IV alpha 1 chain | 1 | 1 | ||||||||
MIRT159142 | NRBP1 | nuclear receptor binding protein 1 | 2 | 2 | ||||||||
MIRT358526 | HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B | 2 | 2 | ||||||||
MIRT441490 | NCEH1 | neutral cholesterol ester hydrolase 1 | 2 | 2 | ||||||||
MIRT443472 | ACPP | acid phosphatase, prostate | 2 | 2 | ||||||||
MIRT464631 | UBE4A | ubiquitination factor E4A | 2 | 2 | ||||||||
MIRT465259 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT473975 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT475168 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT477631 | EFNA1 | ephrin A1 | 2 | 2 | ||||||||
MIRT480100 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT483504 | STMN3 | stathmin 3 | 2 | 4 | ||||||||
MIRT483735 | THSD4 | thrombospondin type 1 domain containing 4 | 2 | 2 | ||||||||
MIRT483847 | UNC5B | unc-5 netrin receptor B | 2 | 2 | ||||||||
MIRT485973 | RTBDN | retbindin | 2 | 2 | ||||||||
MIRT486616 | METTL6 | methyltransferase like 6 | 2 | 2 | ||||||||
MIRT487847 | CLSTN1 | calsyntenin 1 | 2 | 4 | ||||||||
MIRT488675 | WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 2 | 4 | ||||||||
MIRT489046 | PRPF4B | pre-mRNA processing factor 4B | 2 | 2 | ||||||||
MIRT490612 | SLC47A1 | solute carrier family 47 member 1 | 2 | 4 | ||||||||
MIRT490990 | USP22 | ubiquitin specific peptidase 22 | 2 | 2 | ||||||||
MIRT492559 | PRX | periaxin | 2 | 2 | ||||||||
MIRT494667 | ARL8A | ADP ribosylation factor like GTPase 8A | 2 | 2 | ||||||||
MIRT495880 | DPY19L1 | dpy-19 like C-mannosyltransferase 1 | 2 | 2 | ||||||||
MIRT496778 | ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif 14 | 2 | 2 | ||||||||
MIRT499742 | USH1G | USH1 protein network component sans | 2 | 4 | ||||||||
MIRT500371 | ZNF385A | zinc finger protein 385A | 2 | 2 | ||||||||
MIRT503257 | KIF18B | kinesin family member 18B | 2 | 2 | ||||||||
MIRT504511 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | 2 | 2 | ||||||||
MIRT511940 | FAM127B | retrotransposon Gag like 8A | 2 | 2 | ||||||||
MIRT514606 | NDUFA12 | NADH:ubiquinone oxidoreductase subunit A12 | 2 | 4 | ||||||||
MIRT527187 | CLASP1 | cytoplasmic linker associated protein 1 | 2 | 2 | ||||||||
MIRT532494 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT533504 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT539171 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT542735 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 2 | ||||||||
MIRT544647 | PHF8 | PHD finger protein 8 | 2 | 4 | ||||||||
MIRT546232 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | 2 | 2 | ||||||||
MIRT548372 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | 2 | 4 | ||||||||
MIRT555913 | ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | 2 | 2 | ||||||||
MIRT565381 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT568954 | RUNX3 | runt related transcription factor 3 | 2 | 2 | ||||||||
MIRT570205 | RAP1GAP2 | RAP1 GTPase activating protein 2 | 2 | 2 | ||||||||
MIRT573599 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT615364 | CCNF | cyclin F | 2 | 2 | ||||||||
MIRT616102 | HOXB5 | homeobox B5 | 2 | 2 | ||||||||
MIRT619127 | CD40LG | CD40 ligand | 2 | 2 | ||||||||
MIRT634968 | C8orf17 | chromosome 8 open reading frame 17 | 2 | 2 | ||||||||
MIRT646665 | FNBP1 | formin binding protein 1 | 2 | 2 | ||||||||
MIRT649633 | RASA4 | RAS p21 protein activator 4 | 2 | 2 | ||||||||
MIRT658443 | FAM167B | family with sequence similarity 167 member B | 2 | 2 | ||||||||
MIRT660237 | BMP7 | bone morphogenetic protein 7 | 2 | 2 | ||||||||
MIRT669467 | ATL3 | atlastin GTPase 3 | 2 | 2 | ||||||||
MIRT670557 | SHISA2 | shisa family member 2 | 2 | 2 | ||||||||
MIRT671035 | PCDHB2 | protocadherin beta 2 | 2 | 2 | ||||||||
MIRT684255 | TBXA2R | thromboxane A2 receptor | 2 | 2 | ||||||||
MIRT688619 | CYBRD1 | cytochrome b reductase 1 | 3 | 2 | ||||||||
MIRT694346 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT695516 | ALPI | alkaline phosphatase, intestinal | 2 | 2 | ||||||||
MIRT697512 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT700133 | RNF144B | ring finger protein 144B | 2 | 2 | ||||||||
MIRT711667 | TRMT5 | tRNA methyltransferase 5 | 2 | 2 | ||||||||
MIRT712156 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT712463 | KCNC3 | potassium voltage-gated channel subfamily C member 3 | 2 | 2 | ||||||||
MIRT720759 | FAM193A | family with sequence similarity 193 member A | 2 | 2 | ||||||||
MIRT731198 | AKT1 | AKT serine/threonine kinase 1 | 2 | 1 | ||||||||
MIRT755463 | PACS2 | phosphofurin acidic cluster sorting protein 2 | 1 | 1 | ||||||||
MIRT755522 | FOXM1 | forkhead box M1 | 3 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|